High Body Mass Index and Response to Anti-Tumor Necrosis Factor Therapy in Pediatric Crohn's Disease

  • Dawn R. Ebach
  • , Traci W. Jester
  • , Joseph A. Galanko
  • , Ann M. Firestine
  • , Rana Ammoury
  • , Jose Cabrera
  • , Julie Bass
  • , Phillip Minar
  • , Kelly Olano
  • , Peter Margolis
  • , Kelly Sandberg
  • , Tiffany M. Linnville
  • , Jess Kaplan
  • , Lisa Pitch
  • , Steven J. Steiner
  • , Dorsey Bass
  • , Jonathan Moses
  • , Jeremy Adler
  • , Ajay S. Gulati
  • , Prateek Wali
  • Dinesh Pashankar, Anastasia Ivanova, Hans Herfarth, David A. Wohl, Keith J. Benkov, Jennifer Strople, Jillian Sullivan, Jeanne Tung, Zorela Molle-Rios, Shehzad A. Saeed, Athos Bousvaros, Michael D. Kappelman

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1110-1116
Number of pages7
JournalAmerican Journal of Gastroenterology
Volume119
Issue number6
DOIs
StatePublished - Jun 1 2024
Externally publishedYes

ASJC Scopus Subject Areas

  • Hepatology
  • Gastroenterology

Keywords

  • Crohn disease
  • adalimumab
  • body mass index
  • infliximab
  • therapeutic drug monitoring

Cite this